Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T H Florin

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
European Journal of Pharmacology|August 3, 1994
Pressor effect of ethanol in the isolated perfused human placental lobuleS M Taylor, A E Heron, G R Cannell, et al.
Internal Medicine Journal|August 2, 2001
Early Australian experience with infliximab, a chimeric antibody against tumour necrosis factor-alpha, in the treatment of Crohn's disease: is its efficacy augmented by steroid-sparing immunosuppressive therapy? The Infliximab User GroupM Mortimore, P R Gibson, W S Selby, et al.
Inflammation|December 1, 1994
Reversibility of tachyphylaxis to C5A in guinea pig tissues, perfused human placental lobule, and umbilical arteryS M Taylor, A M Finch, A E Heron, et al.
The American Journal of Gastroenterology|November 6, 2001
CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseasesS Vuckovic, T H Florin, D Khalil, et al.
Journal of Pharmacological and Toxicological Methods|November 1, 1995
The effect of C5a and U46619 on the isolated, perfused human placental lobule: development of a method for the online estimation of tissue fluid accumulationA M Finch, A E Heron, S L Tolhurst, et al.
Mucosal Immunology|November 15, 2012
MUC1 and MUC13 differentially regulate epithelial inflammation in response to inflammatory and infectious stimuliY H Sheng, S Triyana, R Wang, et al.
Journal of Medical Genetics|October 19, 2006
Angiotensinogen and transforming growth factor beta1: novel genes in the pathogenesis of Crohn's diseaseG E Hume, E V Fowler, D Lincoln, et al.
Mucosal Immunology|November 26, 2010
An intestinal epithelial defect conferring ER stress results in inflammation involving both innate and adaptive immunityR D Eri, R J Adams, T V Tran, et al.
Oncogene|July 12, 2016
MUC13 protects colorectal cancer cells from death by activating the NF-κB pathway and is a potential therapeutic targetY H Sheng, Y He, S Z Hasnain, et al.
Alimentary Pharmacology & Therapeutics|August 29, 2015
Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high-risk patients - a POCER study analysisP De Cruz, M A Kamm, A L Hamilton, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
European Journal of Pharmacology|August 3, 1994
Pressor effect of ethanol in the isolated perfused human placental lobuleS M Taylor, A E Heron, G R Cannell, et al.
Internal Medicine Journal|August 2, 2001
Early Australian experience with infliximab, a chimeric antibody against tumour necrosis factor-alpha, in the treatment of Crohn's disease: is its efficacy augmented by steroid-sparing immunosuppressive therapy? The Infliximab User GroupM Mortimore, P R Gibson, W S Selby, et al.
Inflammation|December 1, 1994
Reversibility of tachyphylaxis to C5A in guinea pig tissues, perfused human placental lobule, and umbilical arteryS M Taylor, A M Finch, A E Heron, et al.
The American Journal of Gastroenterology|November 6, 2001
CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseasesS Vuckovic, T H Florin, D Khalil, et al.
Journal of Pharmacological and Toxicological Methods|November 1, 1995
The effect of C5a and U46619 on the isolated, perfused human placental lobule: development of a method for the online estimation of tissue fluid accumulationA M Finch, A E Heron, S L Tolhurst, et al.
Mucosal Immunology|November 15, 2012
MUC1 and MUC13 differentially regulate epithelial inflammation in response to inflammatory and infectious stimuliY H Sheng, S Triyana, R Wang, et al.
Journal of Medical Genetics|October 19, 2006
Angiotensinogen and transforming growth factor beta1: novel genes in the pathogenesis of Crohn's diseaseG E Hume, E V Fowler, D Lincoln, et al.
Mucosal Immunology|November 26, 2010
An intestinal epithelial defect conferring ER stress results in inflammation involving both innate and adaptive immunityR D Eri, R J Adams, T V Tran, et al.
Oncogene|July 12, 2016
MUC13 protects colorectal cancer cells from death by activating the NF-κB pathway and is a potential therapeutic targetY H Sheng, Y He, S Z Hasnain, et al.
Alimentary Pharmacology & Therapeutics|August 29, 2015
Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high-risk patients - a POCER study analysisP De Cruz, M A Kamm, A L Hamilton, et al.
Pageof 2